Hazelwood, MO, United States of America

John Schallom


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of John Schallom

Introduction

John Schallom, an accomplished inventor based in Hazelwood, Missouri, has made significant contributions to the field of pharmaceuticals through his innovative work. With a total of three patents to his name, he has focused on creating advanced dosage forms that enhance the safety and efficacy of medications.

Latest Patents

John's latest innovations include extended release, abuse deterrent dosage forms. These dosage forms incorporate crush-resistant controlled-release particles designed to provide abuse deterrent properties. The unique formulation consists of plastic and elastic polymers combined with at least one active pharmaceutical ingredient (API) or its pharmaceutically acceptable salt. The particles are created using a hot melt extrusion process, ensuring that they maintain their integrity and effectiveness in deterring misuse.

Career Highlights

As a key member of Specgx LLC, John Schallom has played an integral role in advancing the company's mission to develop innovative pharmaceutical products. His dedication to research and development has not only led to the creation of groundbreaking dosage forms but has also positioned Specgx LLC as a leader in the pharmaceutical industry.

Collaborations

Throughout his career, John has collaborated with talented individuals, including coworkers Jonathan Gaik and Jaehan Park. Together, they have shared knowledge and expertise, fostering an environment of innovation and creativity that fuels the development of new and effective pharmaceutical solutions.

Conclusion

John Schallom's contributions to the field of pharmaceuticals highlight his role as a forward-thinking inventor. Through his patents and collaborations, he has demonstrated a commitment to developing safer and more effective medication delivery systems. His work continues to inspire advancements in the industry, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…